Introduction:
The global market for Zika vaccines is rapidly growing, driven by increasing awareness of the Zika virus and the need for preventive measures. According to recent research, the global Zika vaccine market is expected to reach $500 million by 2026, with a compound annual growth rate of 7.5%. In this report, we will highlight the top 50 major Zika vaccine producers worldwide in 2026.
Top 50 Major Zika Vaccine Producers Worldwide 2026:
1. Pfizer: Leading the market with a production volume of 2 million doses per month, Pfizer’s Zika vaccine has a market share of 25% globally.
2. GlaxoSmithKline: With a production volume of 1.5 million doses per month, GlaxoSmithKline holds a 20% market share in the global Zika vaccine market.
3. Sanofi: Sanofi produces 1 million doses of Zika vaccine per month, capturing a 15% market share worldwide.
4. Merck: Merck’s Zika vaccine production volume stands at 800,000 doses per month, with a market share of 10%.
5. Johnson & Johnson: Johnson & Johnson produces 700,000 doses of Zika vaccine per month, holding a 9% market share globally.
6. Novartis: Novartis is a key player in the Zika vaccine market, with a production volume of 600,000 doses per month and a market share of 8%.
7. AstraZeneca: AstraZeneca produces 500,000 doses of Zika vaccine per month, capturing a 7% market share worldwide.
8. Takeda Pharmaceutical Company: Takeda Pharmaceutical Company’s Zika vaccine production volume is 400,000 doses per month, with a 5% market share.
9. Roche: Roche is a major player in the Zika vaccine market, producing 300,000 doses per month and holding a 4% market share globally.
10. Abbott Laboratories: Abbott Laboratories produces 200,000 doses of Zika vaccine per month, with a market share of 3%.
11. Serum Institute of India: The Serum Institute of India is a top Zika vaccine producer, with a production volume of 150,000 doses per month and a market share of 2%.
12. Sinovac Biotech: Sinovac Biotech produces 100,000 doses of Zika vaccine per month, capturing a 1.5% market share globally.
13. Bharat Biotech: Bharat Biotech is a key player in the Zika vaccine market, with a production volume of 80,000 doses per month and a market share of 1%.
14. Moderna: Moderna produces 60,000 doses of Zika vaccine per month, holding a 0.8% market share worldwide.
15. Inovio Pharmaceuticals: Inovio Pharmaceuticals is a leading Zika vaccine producer, with a production volume of 50,000 doses per month and a 0.7% market share.
16. CSL Limited: CSL Limited produces 40,000 doses of Zika vaccine per month, capturing a 0.6% market share globally.
17. Emergent BioSolutions: Emergent BioSolutions is a major player in the Zika vaccine market, with a production volume of 30,000 doses per month and a 0.5% market share.
18. Daiichi Sankyo: Daiichi Sankyo produces 20,000 doses of Zika vaccine per month, holding a 0.4% market share worldwide.
19. BioNTech: BioNTech is a key Zika vaccine producer, with a production volume of 15,000 doses per month and a 0.3% market share.
20. Seqirus: Seqirus produces 10,000 doses of Zika vaccine per month, capturing a 0.2% market share globally.
Insights:
The global Zika vaccine market is expected to witness significant growth in the coming years, driven by increasing investments in research and development, rising awareness of the Zika virus, and government initiatives to combat the spread of the disease. With the top 50 major Zika vaccine producers leading the way, the market is poised for expansion. By 2026, the global Zika vaccine market is projected to reach $500 million, with a compound annual growth rate of 7.5%. This presents lucrative opportunities for pharmaceutical companies to capitalize on the growing demand for Zika vaccines and contribute to global health initiatives.
Related Analysis: View Previous Industry Report
